Isidro, María LuisaCordido, Fernando2023-05-022023-05-022010-01-12Isidro ML, Cordido F. Approved and off-label uses of obesity medications, and potential new pharmacologic treatment options. Pharmaceuticals (Basel). 2010 Jan 12;3(1):125-145.1424-8247http://hdl.handle.net/2183/32966Review[Abstract] Available anti-obesity pharmacotherapy options remain very limited and development of more effective drugs has become a priority. The potential strategies to achieve weight loss are to reduce energy intake by stimulating anorexigenic signals or by blocking orexigenic signals, and to increase energy expenditure. This review will focus on approved obesity medications, as well as potential new pharmacologic treatment options.engCreative Commons Attribution 3.0 International License (CC-BY 3.0)http://creativecommons.org/licenses/by/3.0/Drug treatmentGhrelinLeptinObesityOrlistatSibutramineRimonabantjournal articleopen access